Longevity Services & Practice Library
Every article, presentation, spotlight, and news item we've tagged to Longevity Services & Practice.
Showing 217–235 of 235
AI Foundation Models Decode Multi-System Health Data
Human Longevity Inc. established Human Life Foundation Models to develop multimodal AI models for disease prediction and aging biology using de-identified clinical and multi-omic datasets. This infrastructure addresses a critical gap in personalized risk assessment and intervention discovery at scale.
Life Time rolls out SpiroFit metabolic testing to country clubs
Life Time is deploying SpiroFit, a cordless wearable metabolic testing system, across 190 clubs to measure VO2 max and fuel utilization during exercise. The technology generates personalized heart-rate training zones with lab-grade accuracy, enabling members to optimize training intensity and metabolic efficiency.
Perplexity enters the consumer health AI arena
Perplexity has launched an AI-powered health platform that aggregates fragmented health data from medical records, wearables, and provider systems into a unified dashboard, enabling personalized health insights grounded in individual biomarkers and trends. This addresses a critical infrastructure gap in longevity practice: the ability to contextualize health signals across time and across systems, moving beyond isolated data points toward pattern recognition that supports earlier intervention.
Genomic Data Accelerates Precision Drug Discovery for Age-Related Disease
Helix and AstraZeneca established a multi-year partnership granting access to GenoSphere cohorts—genomic datasets paired with longitudinal clinical records spanning 13 years—to accelerate drug discovery across cardiometabolic, respiratory, and autoimmune conditions. This arrangement represents a shift toward precision-medicine-informed development pipelines that integrate genotype with documented clinical outcomes.
Herbalife to acquire personalized supplements company Bioniq
Herbalife's acquisition of Bioniq signals market maturation toward data-driven, individually tailored supplementation based on blood biomarkers and lifestyle data. This shift reflects growing recognition that generic micronutrient approaches fail to address individual metabolic variation and optimization needs.
Linnaeus wins $22m to address aging before decline
ARPA-H has awarded $22 million to Linnaeus Therapeutics to test LNS8801, an oral drug designed to preserve physical and cognitive function in aging before decline occurs. The approach represents a shift from treating age-related disease toward maintaining the integrated capacities that sustain independence and resilience.
It’s Springtime and the Rejuvenation Field Is Flourishing
The rejuvenation research field is advancing through improved diagnostic technology, clinical trial progress, and coordinated business-advocacy efforts. Non-invasive voice and gait biomarkers show promise for early detection of age-related diseases, particularly neurodegenerative conditions and infectious diseases, while the field strengthens its capacity to move discoveries into clinical application.
Where are Europe’s oldest people living? What geography tells us about a fragmenting continent
Regional analysis of 450 European regions over 27 years reveals that life expectancy gains remain sustained in leading regions despite broader stagnation, indicating that longevity plateaus are regional and contextual rather than universal biological limits. Geographic disparities in longevity trajectories suggest that environmental, social, and health system factors continue to drive meaningful variation in human lifespan potential.
Turning your bed into a preventive health platform
Eight Sleep's Pod smart mattress uses continuous biometric monitoring during sleep—tracking heart rate, heart rate variability, and breathing patterns—to shift from reactive treatment to predictive intervention. The company's $1.5 billion valuation reflects a strategic thesis that sleep represents both a high-frequency measurement window and an actionable intervention point for longevity and early disease detection.
People With Positive Outlooks Have Better Aging Outcomes
A longitudinal study of over 11,000 adults aged 65 and older found that 45% showed improvement in cognitive and/or physical functioning over 12 years, with positive age-related beliefs predicting these gains. This challenges the pervasive assumption that chronological aging inevitably produces decline and demonstrates that improvement remains physiologically possible in later life.
Cohort profile Davos Alzheimer’s Collaborative DAC Egypt Cohort
The DAC Egypt Cohort is a longitudinal study designed to identify early biomarkers and risk factors for Alzheimer's disease in an understudied Egyptian population, addressing a critical gap in dementia research outside Western cohorts. Early detection and prevention strategies depend on understanding how disease processes vary across genetic and environmental contexts.
AI Auditing System Tackles Longevity Evidence Hallucination
Forever Healthy released AI4L, an open-source framework that uses adversarial AI workflows and live citation verification to generate evidence-based reviews of longevity interventions while minimizing hallucination and citation fabrication. The system addresses a critical infrastructure gap in longevity science: the scalability problem of evidence synthesis in a field generating evidence faster than traditional human review can process.
Technogym and Google Cloud expand AI fitness
Technogym and Google Cloud are integrating generative AI into fitness platforms to shift from episodic workout protocols toward continuous, anticipatory health management scaled across populations. This partnership pairs four decades of physiological performance data with advanced language models to support adherence—a persistent barrier to preventive health outcomes—while embedding technology into the daily behavioral substrate where health decisions actually occur.
Lilly races to become first longevity Big Pharma
Eli Lilly's $2.75 billion partnership with Insilico Medicine represents a strategic pivot toward AI-driven drug discovery aimed at aging-related pathology beyond current GLP-1 applications. The deal signals that large pharmaceutical companies now view longevity therapeutics as a commercially serious category worthy of substantial investment in discovery infrastructure.
Featured Cover
Plasma proteomic analysis of Swiss centenarians identifies a distinct protein signature associated with preserved youthfulness and longevity. This proteomic fingerprint offers a measurable biomarker set for aging trajectories and potential intervention targets.
Lifetime Cognitive Enrichment Associated With Less Dementia
Lifetime cognitive enrichment from childhood through late life is associated with a 38% reduced dementia risk and delays cognitive decline by 5–7 years. The protective effect accumulates across all life stages, with late-life engagement showing the strongest individual contribution to risk reduction.
Measuring intrinsic capacity at scale
Stanford-led THRIVE coalition secured $34.5 million to develop the first FDA-grade Intrinsic Capacity score, a composite measure integrating wearables, blood biomarkers, and functional assessments to predict 20-year health outcomes. This addresses the field's critical gap: the absence of regulatory-grade measurement infrastructure for aging itself, moving beyond disease-specific endpoints toward quantifiable functional decline.
Ageism Reduction in Clinical Settings Improves Care Quality
An educational intervention combining aging literacy and structured contact with older adults reduced ageist attitudes among healthcare providers in a quasi-experimental design. This addresses a systemic barrier to quality care delivery across medical practice, where provider bias directly influences diagnostic accuracy, treatment intensity, and patient outcomes.
Seveno backs PointFit wearable patch
Seveno Capital's investment in PointFit reflects a market shift toward direct biochemical monitoring via wearable patches that measure lactate and other sweat biomarkers in real time. Continuous metabolic substrate tracking—rather than behavioral proxies like step count—provides actionable insight into energy dynamics, recovery debt, and metabolic flexibility relevant to both performance optimization and early detection of metabolic decline.